Pharma Stocks
-
SciSparc Enters Agreement to Transfer $11.6M Pharma Portfolio
SciSparc (Nasdaq: SPRC) entered a definitive asset-and-share purchase agreement dated October 9,…
Read More » -
Here’s Why We Think Marksans Pharma (NSE:MARKSANS) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering ‘the next big thing’, even if that means buying ‘story stocks’…
Read More » -
Clarity Pharmaceuticals (ASX:CU6) Is Down 5.2% After PSMA Imaging Trial Hits Primary Endpoint Has The Bull Case Changed?
Clarity Pharmaceuticals recently announced that its Co-PSMA Investigator-Initiated Trial led by St Vincent’s Hospital Sydney achieved its primary endpoint, with…
Read More » -
The Bull Case For Alnylam Pharmaceuticals (ALNY) Could Change Following Phase 3 ZENITH Study Launch for Zilebesiran
Alnylam Pharmaceuticals recently announced that the first patient has been dosed in the global Phase 3 ZENITH study, evaluating zilebesiran…
Read More » -
Welcure Drugs Jumps 53% Before 1:10 Bonus & Stock Split
New Delhi, Oct 14, 2025: The shares of Welcure Drugs & Pharmaceuticals Ltd (BSE: 524661) continued their purple patch on the stock exchanges as…
Read More » -
Analyzing Valuation Following Recent Share Price Trends
Luye Pharma Group (SEHK:2186) shares have seen moderate movement over the past month. Investors are keeping a close eye on…
Read More » -
Pharma stock in focus after it plans to acquire BSV’s women’s health portfolio
Synopsis: Mankind Pharma Ltd, remained in focus after announcing a Rs. 797 crore acquisition to strengthen its women’s health portfolio.…
Read More » -
Can Amphastar Pharmaceuticals (AMPH) Navigate Heightened Trade Tensions to Protect Its Supply Chain Advantage?
In the past week, concerns about escalating trade tensions between the US and China, triggered by comments from President Donald…
Read More » -
Ascletis Pharma Advances ASC35 for Obesity Treatment
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert…
Read More » -
Ascendis Pharma (NasdaqGS:ASND): Valuation Insights After TransCon CNP Application Advances European Approval Journey
Ascendis Pharma (NasdaqGS:ASND) just took a major step forward by submitting a Marketing Authorisation Application to the European Medicines Agency…
Read More »
